When Can Strut Thickness Really Matter in Percutaneous Coronary Intervention?

Ajay J Kirtane^{1

2}, Roxana Mehran^{2

3}

Affiliations

¹ Department of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.
² Associate Editor.
³ Icahn School of Medicine at Mount Sinai, New York, New York.

Editorial

Ajay J Kirtane et al. JAMA Cardiol. 2019.

. 2019 Jul 1;4(7):669-670.

doi: 10.1001/jamacardio.2019.1902.

Ajay J Kirtane^{1

2}, Roxana Mehran^{2

3}

¹ Department of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.
² Associate Editor.
³ Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Comment on

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.
Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van der Heijden LC, Kok MM, Danse PW, Schotborgh CE, Scholte M, de Man FHAF, Linssen GCM, von Birgelen C. Buiten RA, et al. JAMA Cardiol. 2019 Jul 1;4(7):659-669. doi: 10.1001/jamacardio.2019.1776. JAMA Cardiol. 2019. PMID: 31111862 Free PMC article. Clinical Trial.